ArticleBMC bioinformatics2012
Effects of protein interaction data integration, representation and reliability on the use of network properties for drug target prediction.
Article in BMC bioinformatics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Signature reversion of three disease-associated gene signatures prioritizes cancer drug repurposing candidates.FEBS open bio · 2024Article
- Exploration of Target Spaces in the Human Genome for Protein and Peptide Drugs.Genomics, proteomics & bioinformatics · 2022Article
- Centrality of drug targets in protein networks.BMC bioinformatics · 2021Article
- DecoPath: a web application for decoding pathway enrichment analysis.NAR genomics and bioinformatics · 2021Article
- Topological network measures for drug repositioning.Briefings in bioinformatics · 2021Article
- Predicting clinically promising therapeutic hypotheses using tensor factorization.BMC bioinformatics · 2019Article
- Systematic interrogation of diverse Omic data reveals interpretable, robust, and generalizable transcriptomic features of clinically successful therapeutic targets.PLoS computational biology · 2018Article
- A novel framework for the identification of drug target proteins: Combining stacked auto-encoders with a biased support vector machine.PloS one · 2017Article
- In silico identification of essential proteins in Corynebacterium pseudotuberculosis based on protein-protein interaction networks.BMC systems biology · 2016Article
- HVint: A Strategy for Identifying Novel Protein-Protein Interactions in Herpes Simplex Virus Type 1.Molecular & cellular proteomics : MCP · 2016Article
- Distinctive Behaviors of Druggable Proteins in Cellular Networks.PLoS computational biology · 2015Article
- Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease.Scientific reports · 2015Article
- Protein-protein interaction detection: methods and analysis.International journal of proteomics · 2014Review
- The human plasma membrane peripherome: visualization and analysis of interactions.BioMed research international · 2014Article
- An empirical study of different approaches for protein classification.TheScientificWorldJournal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrevious studies have noted that drug targets appear to be associated with higher-degree or higher-centrality proteins in interaction networks. These studies explicitly or tacitly make choices of different source databases, data integration strategies, representation of proteins and complexes, and data reliability assumptions. Here we examined how the use of different data integration and representation techniques, or different notions of reliability, may affect the efficacy of degree and centrality as features in drug target prediction.
resultsFifty percent of drug targets have a degree of less than nine, and ninety-five percent have a degree of less than ninety. We found that drug targets are over-represented in higher degree bins - this relationship is only seen for the consolidated interactome and it is not dependent on n-ary interaction data or its representation. Degree acts as a weak predictive feature for drug-target status and using more reliable subsets of the data does not increase this performance. However, performance does increase if only cancer-related drug targets are considered. We also note that a protein's membership in pathway records can act as a predictive feature that is better than degree and that high-centrality may be an indicator of a drug that is more likely to be withdrawn.
conclusionsThese results show that protein interaction data integration and cleaning is an important consideration when incorporating network properties as predictive features for drug-target status. The provided scripts and data sets offer a starting point for further studies and cross-comparison of methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.